Clinical Trials Directory

Trials / Completed

CompletedNCT02739152

TRIAGE: TRIage of Sepsis At emerGency dEpartment

Status
Completed
Phase
Study type
Observational
Enrollment
602 (actual)
Sponsor
BioMérieux · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Sepsis is a serious systemic disease defined as a combination of Systemic Inflammation Response Syndrome (SIRS) plus a confirmed or suspected infection. Untreated or inadequately treated cases can lead to severe sepsis or septic shock; being characterized by high mortality and morbidity. Symptoms and signs of sepsis are variable and this makes clinical recognition and assessment very difficult in particular on Emergency Department (ED) patients due to their infectious illness background and the frequent comorbidities. Also, the severity of the condition may not be apparent at initial contact with ED personnel: patients may arrive at ED with mild clinical manifestation and rapidly progress to critical illness, or rather at the opposite others have benign evolution despite a similar symptoms. In these conditions, the main challenge of ED clinicians is differentiating mild infections from life-threatening ones in the heavy workload of ED environment Objective of TRIAGE project is to identify and validate biomarkers able to predict the clinical worsening of patients freshly admitted at Emergency Department. Targeted population is adult patients freshly admitted at ED, whom blood samples will serve to validate candidate markers.

Conditions

Timeline

Start date
2015-04-01
Primary completion
2018-01-01
Completion
2018-03-01
First posted
2016-04-15
Last updated
2018-04-24

Locations

14 sites across 2 countries: Belgium, France

Source: ClinicalTrials.gov record NCT02739152. Inclusion in this directory is not an endorsement.

TRIAGE: TRIage of Sepsis At emerGency dEpartment (NCT02739152) · Clinical Trials Directory